CHRISTOPHER M YEA plan to sell securities of KalVista Pharmaceuticals, Inc. under Form 144

CHRISTOPHER M YEA filed Form 144 to notify SEC of plan to sell 33800 units of KalVista Pharmaceuticals, Inc. securities around 2026-05-27, with aggregate market value of $905,224.84. The total outstanding units is 53240888.0. The amount planned to be sold represents 0.06% of total outstanding units; Recent transactions in past 3 months include: On 05/26/2026, sold 1966 units for $52645.15; On 05/22/2026, sold 2358 units for $63157.62; On 05/18/2026, sold 1108 units for $29650.08;